Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Aug-23 4:23 PM View:  | Lyell Immunopharma, Inc. (LYEL) | 15-Aug-23 | Sale | 58,020 | $2.28 | $132,286.00 | (1%) 3.96M to 3.9M | |
| 27-Sep-22 6:14 PM View: | Lyell Immunopharma, Inc. (LYEL) | 23-Sep-22 | Market Sale | 11,100 | $6.40 | $71,041.10 | (< 1%) 3.97M to 3.96M | (3%) |
| 23-Jun-21 5:36 PM View: | Lyell Immunopharma, Inc. (LYEL) | 21-Jun-21 | Conversion Duplicate | 3,765,840 | -- | -- | 127% 2.97M to 6.73M | |
| 07-Mar-18 6:21 PM View: | Juno Therapeutics, Inc. (JUNO) | 05-Mar-18 | Disposition (change in control) | 705,525 | $87.00 | $61,380,700.00 | (100%) 705.52K to 0 | |
| 07-Mar-18 6:21 PM View: | Juno Therapeutics, Inc. (JUNO) | 07-Feb-18 | Gift | 23,250 | -- | -- | (3%) 728.77K to 705.52K | |
| 09-Jan-18 9:05 PM View: | Juno Therapeutics, Inc. (JUNO) | 08-Jan-18 | Market Sale (Planned) | 12,724 | $48.21 | $613,392.00 | (2%) 741.5K to 728.77K | |
| 09-Jan-18 9:05 PM View: | Juno Therapeutics, Inc. (JUNO) | 05-Jan-18 | Grant | 248 | -- | -- | < 1% 741.25K to 741.5K | |
| 22-Dec-17 4:58 PM View: | Juno Therapeutics, Inc. (JUNO) | 21-Dec-17 | Market Sale (Planned) | 36,000 | $44.76 | $1,611,360.00 | (5%) 777.25K to 741.25K | (94%) |
| 06-Oct-17 7:31 PM View: | Juno Therapeutics, Inc. (JUNO) | 05-Oct-17 | Grant | 266 | -- | -- | < 1% 776.99K to 777.25K | |
| 08-Sep-17 7:29 PM View: | Juno Therapeutics, Inc. (JUNO) | 07-Sep-17 | Market Sale (Planned) | 12,000 | $42.66 | $511,865.00 | (2%) 788.99K to 776.99K | (103%) |
| 09-Aug-17 7:43 PM View: | Juno Therapeutics, Inc. (JUNO) | 07-Aug-17 | Market Sale (Planned) | 12,000 | $30.34 | $364,091.00 | (1%) 800.99K to 788.99K | (186%) |
| 07-Jul-17 7:49 PM View: | Juno Therapeutics, Inc. (JUNO) | 07-Jul-17 | Market Sale (Planned) | 24,000 | $29.39 | $705,320.00 | (3%) 824.99K to 800.99K | (195%) |
| 07-Jul-17 7:49 PM View: | Juno Therapeutics, Inc. (JUNO) | 05-Jul-17 | Grant | 380 | -- | -- | < 1% 824.61K to 824.99K | |
| 09-Jun-17 7:37 PM View: | Juno Therapeutics, Inc. (JUNO) | 07-Jun-17 | Market Sale (Planned) | 24,000 | $23.60 | $566,362.00 | (3%) 848.61K to 824.61K | (268%) |
| 06-Apr-17 4:50 PM View: | Juno Therapeutics, Inc. (JUNO) | 05-Apr-17 | Grant | 514 | -- | -- | < 1% 848.09K to 848.61K | |
| 09-Jan-17 5:06 PM View: | Juno Therapeutics, Inc. (JUNO) | 05-Jan-17 | Grant | 591 | -- | -- | < 1% 847.5K to 848.09K | |
| 17-Oct-16 8:44 PM View: | Juno Therapeutics, Inc. (JUNO) | 05-Oct-16 | Grant | 401 | -- | -- | < 1% 847.1K to 847.5K | |
| 05-Jul-16 7:45 PM View: | Juno Therapeutics, Inc. (JUNO) | 05-Jul-16 | Grant | 300 | -- | -- | < 1% 846.8K to 847.1K | |
| 24-Jun-16 5:56 PM View: | Juno Therapeutics, Inc. (JUNO) | 24-Jun-16 | Market Sale (Planned) | 12,000 | $40.71 | $488,496.00 | (1%) 858.8K to 846.8K | (161%) |
| 20-May-16 5:35 PM View: | Juno Therapeutics, Inc. (JUNO) | 18-May-16 | Market Sale (Planned) | 12,000 | $40.00 | $480,000.00 | (1%) 870.8K to 858.8K | 34% |
| 19-Apr-16 7:17 PM View: | Juno Therapeutics, Inc. (JUNO) | 15-Apr-16 | Market Sale (Planned) | 12,000 | $42.90 | $514,857.00 | (1%) 882.8K to 870.8K | 38% |
| 07-Apr-16 4:23 PM View: | Juno Therapeutics, Inc. (JUNO) | 05-Apr-16 | Grant | 300 | -- | -- | < 1% 882.5K to 882.8K | |
| 22-Mar-16 6:42 PM View: | Juno Therapeutics, Inc. (JUNO) | 22-Mar-16 | Market Sale (Planned) | 12,000 | $40.00 | $480,000.00 | (1%) 894.5K to 882.5K | 34% |
| 02-Mar-16 9:00 PM View: | Juno Therapeutics, Inc. (JUNO) | 02-Mar-16 | Market Sale | 24,000 | $40.42 | $970,023.00 | (3%) 918.5K to 894.5K | (163%) |
| 01-Feb-16 8:11 PM View: | Illumina Inc. (ILMN) | 29-Jan-16 | Payment of Exercise | 253 | $157.95 | $39,961.30 | (1%) 23.1K to 22.85K | (90%) |
| 17-Dec-15 7:01 PM View: | Juno Therapeutics, Inc. (JUNO) | 15-Dec-15 | Market Sale | 12,000 | $45.71 | $548,562.00 | (1%) 930.5K to 918.5K | (132%) |
| 16-Nov-15 5:16 PM View: | Illumina Inc. (ILMN) | 13-Nov-15 | Market Sale (Planned) | 730 | $163.52 | $119,370.00 | (3%) 23.83K to 23.1K | (83%) |
| 13-Nov-15 8:00 PM View: | Juno Therapeutics, Inc. (JUNO) | 13-Nov-15 | Market Sale | 12,000 | $49.51 | $594,078.00 | (1%) 942.5K to 930.5K | (115%) |
| 06-Nov-15 8:43 PM View: | Illumina Inc. (ILMN) | 05-Nov-15 | Payment of Exercise | 186 | $154.75 | $28,783.50 | (< 1%) 24.02K to 23.83K | (94%) |
| 16-Oct-15 7:00 PM View: | Juno Therapeutics, Inc. (JUNO) | 15-Oct-15 | Market Sale | 8,000 | $50.00 | $400,000.00 | (< 1%) 950.5K to 942.5K | (112%) |
| 13-Oct-15 6:13 AM View: | Juno Therapeutics, Inc. (JUNO) | 12-Oct-15 | Market Sale | 16,000 | $50.00 | $800,008.00 | (2%) 966.5K to 950.5K | (112%) |
| 29-Sep-15 4:26 PM View: | Illumina Inc. (ILMN) | 28-Sep-15 | Market Sale (Planned) | 423 | $173.20 | $73,263.60 | (2%) 24.44K to 24.02K | (73%) |
| 25-Sep-15 9:11 PM View: | Illumina Inc. (ILMN) | 23-Sep-15 | Payment of Exercise | 509 | $189.93 | $96,674.40 | (2%) 24.95K to 24.44K | (58%) |
| 17-Jul-15 6:00 PM View: | Juno Therapeutics, Inc. (JUNO) | 15-Jul-15 | Market Sale | 8,000 | $53.34 | $426,727.00 | (< 1%) 974.5K to 966.5K | (99%) |
| 25-Jun-15 5:30 PM View: | Juno Therapeutics, Inc. (JUNO) | 23-Jun-15 | Market Sale | 8,000 | $52.29 | $418,302.00 | (< 1%) 982.5K to 974.5K | (103%) |
| 11-Mar-15 7:46 PM View: | Illumina Inc. (ILMN) | 10-Mar-15 | Market Sale (Planned) | 1,186 | $191.75 | $227,416.00 | (5%) 26.13K to 24.95K | (56%) |
| 02-Feb-15 9:28 PM View: | Illumina Inc. (ILMN) | 29-Jan-15 | Payment of Exercise | 246 | $200.00 | $49,200.00 | (< 1%) 26.38K to 26.13K | (50%) |
| 09-Dec-14 8:10 PM View: | Illumina Inc. (ILMN) | 05-Dec-14 | Grant | 1,975 | -- | -- | 8% 24.41K to 26.38K | |
| 24-Sep-14 7:38 PM View: | Illumina Inc. (ILMN) | 23-Sep-14 | Payment of Exercise | 509 | $167.27 | $85,140.40 | (2%) 24.91K to 24.41K | (79%) |
| 31-Jan-14 9:40 PM View: | Illumina Inc. (ILMN) | 29-Jan-14 | Grant | 2,344 | -- | -- | 10% 22.57K to 24.91K |